The Nation - News from May 9, 1989
U.S. District Judge Dickinson Debevoise ruled in Newark, N.J., that two insurance companies must pay for an expensive new anti-cancer procedure for a man with a bone marrow malignancy. Nicolae Dozsa, 54, of Jefferson Township, N.J., was accepted in December for autologous bone marrow transfer at Johns Hopkins Hospital in Baltimore. He has been unable to receive the treatment because Crum & Forster Organizations, the insurance company for which his wife works, refused to cover it, ruling that ABMT is experimental for patients with multiple myeloma. Debevoise said that Crum & Forster and Prudential Insurance Co. of America, which administers the plan, failed to abide by their own policy. The estimated cost of the treatment is $75,000 to $125,000.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
